{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["antibiotic resistance", "isocyanide", "multicomponent reactions", "public health"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37237752", "DateRevised": {"Year": "2023", "Month": "05", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "05", "Day": "04"}], "Language": ["eng"], "ELocationID": ["849", "10.3390/antibiotics12050849"], "Journal": {"ISSN": "2079-6382", "JournalIssue": {"Volume": "12", "Issue": "5", "PubDate": {"Year": "2023", "Month": "May", "Day": "04"}}, "Title": "Antibiotics (Basel, Switzerland)", "ISOAbbreviation": "Antibiotics (Basel)"}, "ArticleTitle": "The Discovery of Novel Antimicrobial Agents through the Application of Isocyanide-Based Multicomponent Reactions.", "Abstract": {"AbstractText": ["Multicomponent reactions (MCR) have been used to synthesize a wide range of analogs from several classes of heterocyclic compounds, with multifaceted medicinal uses. The synthesis of highly functionalized molecules in a single pot is a unique property of MCR, allowing researchers to quickly assemble libraries of compounds of biological interest and uncover novel leads as possible therapeutic agents. Isocyanide-based multicomponent reactions have proven to be extremely effective at swiftly specifying members of compound libraries, particularly in the discovery of drugs. The understanding of structure-activity correlations that drive the development of new goods and technology requires structural variety in these libraries. In today's world, antibiotic resistance is a major ongoing problem that poses risks to public health. The implementation of isocyanide-based multicomponent reactions upholds a significant potential in this regard. By utilizing such reactions, new antimicrobial compounds can be discovered and subsequently used to fight against such concerns. This study discusses the recent developments in antimicrobial medication discovery using isocyanide-based multicomponent reactions (IMCRs). Furthermore, the article emphasizes the potential of IMCRs (Isocyanide-based multicomponent based reactions) in the near future."]}, "AuthorList": [{"Identifier": ["0000-0002-1258-4088"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "GenLab Biosolutions Private Limited, Bangalore 560043, Karnataka, India."}, {"Identifier": [], "Affiliation": "Department of Biomedical Sciences, School of Life Sciences, Anglia Ruskin University, Cambridge CB1 1PT, UK."}, {"Identifier": [], "Affiliation": "School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK."}, {"Identifier": [], "Affiliation": "SCAMT Institute, ITMO University, St. Petersburg 197101, Russia."}], "LastName": "Quazi", "ForeName": "Sameer", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Asian Network of Research on Anti-Diabetic Plants (ANRAP), Dhaka 1216, Bangladesh."}], "LastName": "Rashid", "ForeName": "Maliha Tabassum", "Initials": "MT"}, {"Identifier": ["0000-0003-3308-1321"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Zoology, Guru Ghasidas University, Bilaspur 495009, Chhattisgarh, India."}], "LastName": "Malik", "ForeName": "Javid Ahmad", "Initials": "JA"}, {"Identifier": ["0000-0001-6999-972X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Navya Care, Bangalore 560001, Karnataka, India."}], "LastName": "Gavas", "ForeName": "Shreelaxmi", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Antibiotics (Basel)", "NlmUniqueID": "101637404", "ISSNLinking": "2079-6382"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Zarganes-Tzitzikas T., Chandgude A.L., D\u00f6mling A. Multicomponent reactions, union of MCRs and beyond. Chem. Rec. 2015;15:981\u2013996. doi: 10.1002/tcr.201500201.", "ArticleIdList": ["10.1002/tcr.201500201", "26455350"]}, {"Citation": "Afshari R., Shaabani A. Materials functionalization with multicomponent reactions: State of the art. ACS Comb. Sci. 2018;20:499\u2013528. doi: 10.1021/acscombsci.8b00072.", "ArticleIdList": ["10.1021/acscombsci.8b00072", "30106275"]}, {"Citation": "Kruljec N., Bratkovi\u010d T. Alternative affinity ligands for immunoglobulins. Bioconjug. Chem. 2017;28:2009\u20132030. doi: 10.1021/acs.bioconjchem.7b00335.", "ArticleIdList": ["10.1021/acs.bioconjchem.7b00335", "28696676"]}, {"Citation": "Lin W., Zhang W., Sun T., Liu S., Zhu Y., Xie Z. Rational design of polymeric nanoparticles with tailorable biomedical functions for cancer therapy. ACS Appl. Mater. Interfaces. 2017;9:29612\u201329622. doi: 10.1021/acsami.7b10763.", "ArticleIdList": ["10.1021/acsami.7b10763", "28812347"]}, {"Citation": "Kambe T., Correia B.E., Niphakis M.J., Cravatt B.F. Mapping the protein interaction landscape for fully functionalized small-molecule probes in human cells. J. Am. Chem. Soc. 2014;136:10777\u201310782. doi: 10.1021/ja505517t.", "ArticleIdList": ["10.1021/ja505517t", "PMC4120992", "25045785"]}, {"Citation": "Garc\u00eda-Gonz\u00e1lez M.C., Aguilar-Granda A., Zamudio-Medina A., Miranda L.D., Rodr\u00edguez-Molina B. Synthesis of structurally diverse emissive molecular rotors with four-component ugi stators. J. Org. Chem. 2018;83:2570\u20132581. doi: 10.1021/acs.joc.7b02858.", "ArticleIdList": ["10.1021/acs.joc.7b02858", "29457731"]}, {"Citation": "Boukis A.C., Reiter K., Fr\u00f6lich M., Hofheinz D., Meier M.A.R. Multicomponent reactions provide key molecules for secret communication. Nat. Commun. 2018;9:1439. doi: 10.1038/s41467-018-03784-x.", "ArticleIdList": ["10.1038/s41467-018-03784-x", "PMC5897361", "29651145"]}, {"Citation": "Domling A. Recent advances in isocyanide-based multicomponent chemistry. ChemInform. 2003;34 doi: 10.1002/chin.200301251.", "ArticleIdList": ["10.1002/chin.200301251", "12023110"]}, {"Citation": "Gordon E.M., Barrett R.W., Dower W.J., Fodor S.P.A., Gallop M.A. Applications of combinatorial technologies to drug discovery. 2. combinatorial organic synthesis, library screening strategies, and future directions. J. Med. Chem. 1994;37:1385\u20131401. doi: 10.1021/jm00036a001.", "ArticleIdList": ["10.1021/jm00036a001", "8182695"]}, {"Citation": "Golisade A., Wiesner J., Herforth C., Joma H., Link A. Anti-Malarial activity of N6-Substituted adenosine derivatives. Part I Med. Bioorg. Med. Chem. 2002;10:769\u2013777. doi: 10.1016/S0968-0896(01)00331-5.", "ArticleIdList": ["10.1016/S0968-0896(01)00331-5", "11814867"]}, {"Citation": "Teague S.J., Davis A.M., Leeson P.D., Oprea T. The design of leadlike combinatorial libraries. Angew. Chem. Int. Ed. Engl. 1999;38:3743\u20133748. doi: 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U.", "ArticleIdList": ["10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U", "10649345"]}, {"Citation": "Obert R., Armstrong W., Combs A.P., Tempest P.A., Brown S.D. Multiple-component condensation strategies for combinatorial library synthesis. Acc. Chem. Res. 1996;29:123\u2013131."}, {"Citation": "Orru R.V.A., de Greef M. Recent advances in solution-phase multicomponent methodology for the synthesis of heterocyclic compounds. ChemInform. 2003;34 doi: 10.1002/chin.200340290.", "ArticleIdList": ["10.1002/chin.200340290"]}, {"Citation": "Li J.J. Name Reactions. Springer; Berlin/Heidelberg, Germany: 2003. Strecker amino acid synthesis; pp. 399\u2013400."}, {"Citation": "Hantzsch A. Ueber die synthese pyridinartiger verbindungen aus acetessig\u00e4ther und aldehydammoniak. Justus Liebigs Ann. Chem. 1882;215:1\u201382. doi: 10.1002/jlac.18822150102.", "ArticleIdList": ["10.1002/jlac.18822150102"]}, {"Citation": "Biginelli P. Ueber aldehyduramide des acetessig\u00e4thers. II. Ber. Dtsch. Chem. Ges. 1891;24:2962\u20132967. doi: 10.1002/cber.189102402126.", "ArticleIdList": ["10.1002/cber.189102402126"]}, {"Citation": "Biginelli P. Aldehydureidderivate des acet-und oxalessig\u00e4thers. Ber. Dtsch. Chem. Ges. 1893;26:447\u2013450."}, {"Citation": "Kappe C.O. 100 Tetrahedron 1993, 49, 6937. (b) kappe, co. Acc. Chem. Res. 2000;33:879. doi: 10.1021/ar000048h.", "ArticleIdList": ["10.1021/ar000048h", "11123887"]}, {"Citation": "Kappe C.O. A reexamination of the mechanism of the biginelli dihydropyrimidine synthesis. Support for an N-Acyliminium ion intermediate1. J. Org. Chem. 1997;62:7201\u20137204. doi: 10.1021/jo971010u.", "ArticleIdList": ["10.1021/jo971010u", "11671828"]}, {"Citation": "Sotiri K., Hilgert S., Mannich M., Bleninger T., Fuchs S. Implementation of comparative detection approaches for the accurate assessment of sediment thickness and sediment volume in the passa\u00fana reservoir. J. Environ. Manag. 2021;287:112298. doi: 10.1016/j.jenvman.2021.112298.", "ArticleIdList": ["10.1016/j.jenvman.2021.112298", "33730673"]}, {"Citation": "Ugi I. Angewandte Chemie-International Edition. Wiley-VCH Verlag GmbH; Berlin, Germany: 1959."}, {"Citation": "Ugi I., Steinbr\u00fcckner C. \u00dcber ein neues kondensations-prinzip. Angew. Chem. Weinh. Bergstr. Ger. 1960;72:267\u2013268. doi: 10.1002/ange.19600720709.", "ArticleIdList": ["10.1002/ange.19600720709"]}, {"Citation": "Ugi I. The \u03b1-addition of immonium ions and anions to isonitriles accompanied by secondary reactions. Angew. Chem. Int. Ed. Engl. 1962;1:8\u201321. doi: 10.1002/anie.196200081.", "ArticleIdList": ["10.1002/anie.196200081"]}, {"Citation": "Gokel G., L\u00fcdke G., Ugi I. In: Isonitrile Chemistry. Ugi I., editor. Academic Press; New York, NY, USA: 2012."}, {"Citation": "Passerini M. Composto del p-isontril-azobenzolo con acetone ed acido acetico. Gazz. Chim. Ital. 1921;51:126\u2013129."}, {"Citation": "Neochoritis C.G., Zhao T., D\u00f6mling A. Tetrazoles via multicomponent reactions. Chem. Rev. 2019;119:1970\u20132042. doi: 10.1021/acs.chemrev.8b00564.", "ArticleIdList": ["10.1021/acs.chemrev.8b00564", "PMC6376451", "30707567"]}, {"Citation": "Kakuchi R. The dawn of polymer chemistry based on multicomponent reactions. Polym. J. 2019;51:945\u2013953. doi: 10.1038/s41428-019-0209-0.", "ArticleIdList": ["10.1038/s41428-019-0209-0"]}, {"Citation": "Quazi S., Gavas S., Malik J.A., Suman K.S., Haider Z. In-silico pharmacophore and molecular docking based drug discovery against marburg virus\u2019s viral protein 35; A potent of MAVD. bioRxiv. 2021 doi: 10.1101/2021.07.01.450693. preprint .", "ArticleIdList": ["10.1101/2021.07.01.450693"]}, {"Citation": "Lieke W. Ueber das cyanallyl. Justus Liebigs Ann. Chem. 1859:316\u2013321. doi: 10.1002/jlac.18591120307.", "ArticleIdList": ["10.1002/jlac.18591120307"]}, {"Citation": "Gautier A. Ueber die einwirkung des chlorwasserstoffs u. a. Auf das aethyl- und methylcyan\u00fcr. Ann. Chem. Pharm. 1867;142:289\u2013294. doi: 10.1002/jlac.18671420304.", "ArticleIdList": ["10.1002/jlac.18671420304"]}, {"Citation": "Ugi I., D\u00f6mling A., Gruber B., Almstetter M. Multicomponent reactions and their libraries\u2014A new approach to preparative organic chemistry. Croat. Chem. Acta. 1997;70:631\u2013647."}, {"Citation": "Ugi I. Neuere methoden der pr\u00e4parativen organischen chemie IV: Mit sekund\u00e4r-reaktionen gekoppelte \u03b1-additionen von immonium-ionen und anionen an isonitrile. Angew. Chem. 1962;74:9\u201322. doi: 10.1002/ange.19620740103.", "ArticleIdList": ["10.1002/ange.19620740103"]}, {"Citation": "Ugi I., Meyr R., Fetzer U., Steinbr\u00fcckner C. Versuche mit isonitrilen. Angew. Chem. 1959;71:386."}, {"Citation": "Arshady R., Ugi I. Solid phase peptide synthesis by four component condensation: Peptide formation on an isocyano polymer support. Z. Naturforsch. B J. Chem. Sci. 1981;36:1202\u20131203. doi: 10.1515/znb-1981-0933.", "ArticleIdList": ["10.1515/znb-1981-0933"]}, {"Citation": "Oertel K., Zech G., Kunz H. Stereoselective combinatorial ugi-multicomponent synthesis on solid phase this work was supported by the deutsche forschungsgemeinschaft and by the fonds der chemischen industrie. Angew. Chem. Int. Ed. Engl. 2000;39:1431\u20131433. doi: 10.1002/(SICI)1521-3773(20000417)39:8<1431::AID-ANIE1431>3.0.CO;2-N.", "ArticleIdList": ["10.1002/(SICI)1521-3773(20000417)39:8<1431::AID-ANIE1431>3.0.CO;2-N", "10777631"]}, {"Citation": "Bienaym\u00e9 H., Bouzid K. A new heterocyclic multicomponent reaction for the combinatorial synthesis of fused 3-aminoimidazoles. Angew. Chem. Int. Ed. 1998;37:2234\u20132237. doi: 10.1002/(SICI)1521-3773(19980904)37:16<2234::AID-ANIE2234>3.0.CO;2-R.", "ArticleIdList": ["10.1002/(SICI)1521-3773(19980904)37:16<2234::AID-ANIE2234>3.0.CO;2-R", "29711433"]}, {"Citation": "Blackburn C., Guan B., Fleming P., Shiosaki K., Tsai S. Parallel synthesis of 3-aminoimidazo [1,2-a] pyridines and pyrazines by a new three-component condensation. Tetrahedron Lett. 1998;39:3635\u20133638. doi: 10.1016/S0040-4039(98)00653-4.", "ArticleIdList": ["10.1016/S0040-4039(98)00653-4"]}, {"Citation": "Groebke K., Weber L., Mehlin F. ChemInform abstract: Synthesis of imidazo [1,2-a] annulated pyridines, pyrazines, and pyrimidines by a novel three-component condensation. ChemInform. 2010;29 doi: 10.1002/chin.199839120.", "ArticleIdList": ["10.1002/chin.199839120"]}, {"Citation": "Ugi I., Meyr R., Isonitrile V. Erweiterter anwendungsbereich der passerini-reaktion. Chem. Ber. 1961;94:2229\u20132233. doi: 10.1002/cber.19610940844.", "ArticleIdList": ["10.1002/cber.19610940844"]}, {"Citation": "Wang S.-X., Wang M.-X., Wang D.-X., Zhu J. Catalytic enantioselective passerini three-component reaction. Angew. Chem. Int. Ed. Engl. 2008;47:388\u2013391. doi: 10.1002/anie.200704315.", "ArticleIdList": ["10.1002/anie.200704315", "18008290"]}, {"Citation": "Brioche J., Masson G., Zhu J. Passerini three-component reaction of alcohols under catalytic aerobic oxidative conditions. Org. Lett. 2010;12:1432\u20131435. doi: 10.1021/ol100012y.", "ArticleIdList": ["10.1021/ol100012y", "20218637"]}, {"Citation": "Yanai H., Oguchi T., Taguchi T. Direct alkylative passerini reaction of aldehydes, isocyanides, and free aliphatic alcohols catalyzed by indium (III) triflate. J. Org. Chem. 2009;74:3927\u20133929. doi: 10.1021/jo900354e.", "ArticleIdList": ["10.1021/jo900354e", "19374384"]}, {"Citation": "El Kaim L., Gizolme M., Grimaud L. O-arylative passerini reactions. Org. Lett. 2006;8:5021\u20135023. doi: 10.1021/ol0617502.", "ArticleIdList": ["10.1021/ol0617502", "17048833"]}, {"Citation": "Soeta T., Kojima Y., Ukaji Y., Inomata K. O-silylative passerini reaction: A new one-pot synthesis of \u03b1-siloxyamides. Org. Lett. 2010;12:4341\u20134343. doi: 10.1021/ol101763w.", "ArticleIdList": ["10.1021/ol101763w", "20822154"]}, {"Citation": "Sunderhaus J.D., Martin S.F. Applications of multicomponent reactions to the synthesis of diverse heterocyclic scaffolds. Chemistry. 2009;15:1300\u20131308. doi: 10.1002/chem.200802140.", "ArticleIdList": ["10.1002/chem.200802140", "PMC2803615", "19132705"]}, {"Citation": "Paulvannan K. Preparation of tricyclic nitrogen heterocycles via tandem four-component condensation/intramolecular diels-alder reaction. Tetrahedron Lett. 1999;40:1851\u20131854. doi: 10.1016/S0040-4039(99)00072-6.", "ArticleIdList": ["10.1016/S0040-4039(99)00072-6"]}, {"Citation": "Koopmanschap G., Ruijter E., Orru R.V.A. Isocyanide-based multicomponent reactions towards cyclic constrained peptidomimetics. Beilstein J. Org. Chem. 2014;10:544\u2013598. doi: 10.3762/bjoc.10.50.", "ArticleIdList": ["10.3762/bjoc.10.50", "PMC3943360", "24605172"]}, {"Citation": "Bonnaterre F., Bois-Choussy M., Zhu J. Rapid access to oxindoles by the combined use of an ugi four-component reaction and a microwave-assisted intramolecular buchwald\u2212hartwig amidation reaction. Org. Lett. 2006;8:4351\u20134354. doi: 10.1021/ol061755z.", "ArticleIdList": ["10.1021/ol061755z", "16956224"]}, {"Citation": "White C.J., Yudin A.K. Contemporary strategies for peptide macrocyclization. Nat. Chem. 2011;3:509\u2013524. doi: 10.1038/nchem.1062.", "ArticleIdList": ["10.1038/nchem.1062", "21697871"]}, {"Citation": "Quazi S., Jangi R. Artificial intelligence and machine learning in medicinal chemistry and validation of emerging drug targets.  [(accessed on 1 March 2023)];Adv. Control. Drug Deliv. Syst. 2021 :27\u201343. Available online:  https://www.igi-global.com/chapter/artificial-intelligence-and-machine-learning-in-medicinal-chemistry-and-validation-of-emerging-drug-targets/300400."}, {"Citation": "Hulme C., Lee Y.-S. Emerging approaches for the syntheses of bicyclic imidazo [1,2-x]-heterocycles. Mol. Divers. 2008;12:1\u201315. doi: 10.1007/s11030-008-9072-1.", "ArticleIdList": ["10.1007/s11030-008-9072-1", "18409015"]}, {"Citation": "Devi N., Rawal R.K., Singh V. Diversity-oriented synthesis of fused-imidazole derivatives via groebke\u2013blackburn\u2013bienayme reaction: A review. Tetrahedron. 2015;71:183\u2013232. doi: 10.1016/j.tet.2014.10.032.", "ArticleIdList": ["10.1016/j.tet.2014.10.032"]}, {"Citation": "Akritopoulou-Zanze I., Wakefield B.D., Gasiecki A., Kalvin D., Johnson E.F., Kovar P., Djuric S.W. Scaffold oriented synthesis. Part 4: Design, synthesis and biological evaluation of novel 5-substituted indazoles as potent and selective kinase inhibitors employing heterocycle forming and multicomponent reactions. Bioorg. Med. Chem. Lett. 2011;21:1480\u20131483. doi: 10.1016/j.bmcl.2011.01.001.", "ArticleIdList": ["10.1016/j.bmcl.2011.01.001", "21288717"]}, {"Citation": "Baviskar A.T., Madaan C., Preet R., Mohapatra P., Jain V., Agarwal A., Guchhait S.K., Kundu C.N., Banerjee U.C., Bharatam P.V. N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase II\u03b1 and induce apoptosis in G1/S phase. J. Med. Chem. 2011;54:5013\u20135030. doi: 10.1021/jm200235u.", "ArticleIdList": ["10.1021/jm200235u", "21644529"]}, {"Citation": "Shukla N.M., Salunke D.B., Yoo E., Mutz C.A., Balakrishna R., David S.A. Antibacterial activities of groebke\u2013blackburn\u2013bienaym\u00e9-derived imidazo [1,2-a] pyridin-3-amines. Bioorg. Med. Chem. 2012;20:5850\u20135863. doi: 10.1016/j.bmc.2012.07.052.", "ArticleIdList": ["10.1016/j.bmc.2012.07.052", "PMC3448811", "22925449"]}, {"Citation": "Burchak O.N., Mugherli L., Ostuni M., Lacap\u00e8re J.J., Balakirev M.Y. Combinatorial discovery of fluorescent pharmacophores by multicomponent reactions in droplet arrays. J. Am. Chem. Soc. 2011;133:10058\u201310061. doi: 10.1021/ja204016e.", "ArticleIdList": ["10.1021/ja204016e", "21644551"]}, {"Citation": "Elleder D., Baiga T.J., Russell R.L., Naughton J.A., Hughes S.H., Noel J.P., Young J.A.T. Identification of a 3-aminoimidazo [1,2-a] pyridine inhibitor of HIV-1 reverse transcriptase. Virol. J. 2012;9:305. doi: 10.1186/1743-422X-9-305.", "ArticleIdList": ["10.1186/1743-422X-9-305", "PMC3560175", "23231773"]}, {"Citation": "Bode M.L., Gravestock D., Moleele S.S., van der Westhuyzen C.W., Pelly S.C., Steenkamp P.A., Hoppe H.C., Khan T., Nkabinde L.A. Imidazo [1,2-a] pyridin-3-amines as potential HIV-1 non-nucleoside reverse transcriptase inhibitors. Bioorg. Med. Chem. 2011;19:4227\u20134237. doi: 10.1016/j.bmc.2011.05.062.", "ArticleIdList": ["10.1016/j.bmc.2011.05.062", "21700466"]}, {"Citation": "Urbancic K.F., Ierino F., Phillips E., Mount P.F., Mahony A., Trubiano J.A. Taking the challenge: A protocolized approach to optimize pneumocystis pneumonia prophylaxis in renal transplant recipients. Am. J. Transpl. 2018;18:462\u2013466. doi: 10.1111/ajt.14498.", "ArticleIdList": ["10.1111/ajt.14498", "PMC5790633", "28898546"]}, {"Citation": "Heaslet H., Harris M., Fahnoe K., Sarver R., Putz H., Chang J., Subramanyam C., Barreiro G., Miller J.R. Structural comparison of chromosomal and exogenous dihydrofolate reductase from staphylococcus aureus in complex with the potent inhibitor trimethoprim. Proteins. 2009;76:706\u2013717. doi: 10.1002/prot.22383.", "ArticleIdList": ["10.1002/prot.22383", "19280600"]}, {"Citation": "Zhou W., Scocchera E.W., Wright D.L., Anderson A.C. Antifolates as effective antimicrobial agents: New generations of trimethoprim analogs. Medchemcomm. 2013;4:908. doi: 10.1039/c3md00104k.", "ArticleIdList": ["10.1039/c3md00104k"]}, {"Citation": "Quazi S., Malik J., Suman K.S., Capuzzo A.M., Haider Z. Discovery of potential drug-like compounds against viral protein (VP40) of marburg virus using pharmacophoric based virtual screening from ZINC database. bioRxiv. 2021 doi: 10.1101/2021.05.13.444037.", "ArticleIdList": ["10.1101/2021.05.13.444037"]}, {"Citation": "Lombardo M.N., G-Dayanandan N., Wright D.L., Anderson A.C. Crystal structures of trimethoprim-resistant DfrA1 rationalize potent inhibition by propargyl-linked antifolates. ACS Infect. Dis. 2016;2:149\u2013156. doi: 10.1021/acsinfecdis.5b00129.", "ArticleIdList": ["10.1021/acsinfecdis.5b00129", "PMC5108240", "27624966"]}, {"Citation": "Rashid U., Ahmad W., Hassan S.F., Qureshi N.A., Niaz B., Muhammad B., Imdad S., Sajid M. Design, synthesis, antibacterial activity and docking study of some new trimethoprim derivatives. Bioorg. Med. Chem. Lett. 2016;26:5749\u20135753. doi: 10.1016/j.bmcl.2016.10.051.", "ArticleIdList": ["10.1016/j.bmcl.2016.10.051", "28327306"]}, {"Citation": "Pedrola M., Jorba M., Jardas E., Jardi F., Ghashghaei O., Vi\u00f1as M., Lavilla R. Multicomponent reactions upon the known drug trimethoprim as a source of novel antimicrobial agents. Front. Chem. 2019;7:475. doi: 10.3389/fchem.2019.00475.", "ArticleIdList": ["10.3389/fchem.2019.00475", "PMC6621506", "31334221"]}, {"Citation": "Ghashghaei O., Caputo S., Sintes M., Rev\u00e9s M., Kielland N., Estarellas C., Luque F.J., Avi\u00f1\u00f3 A., Eritja R., Serna-Gallego A., et al. Multiple multicomponent reactions: Unexplored substrates, selective processes, and versatile chemotypes in biomedicine. Chemistry. 2018;24:14513\u201314521. doi: 10.1002/chem.201802877.", "ArticleIdList": ["10.1002/chem.201802877", "29974986"]}, {"Citation": "Dolce D., Neri S., Grisotto L., Campana S., Ravenni N., Miselli F., Camera E., Zavataro L., Braggion C., Fiscarelli E.V., et al. Methicillin-resistant staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter study. PLoS ONE. 2019;14:e0213497. doi: 10.1371/journal.pone.0213497.", "ArticleIdList": ["10.1371/journal.pone.0213497", "PMC6430412", "30901344"]}, {"Citation": "Lo D.K., Muhlebach M.S., Smyth A.R. Interventions for the eradication of meticillin-resistant staphylococcus aureus (MRSA) in people with cystic fibrosis. Cochrane Database Syst. Rev. 2018;7:CD009650. doi: 10.1002/14651858.CD009650.pub4.", "ArticleIdList": ["10.1002/14651858.CD009650.pub4", "PMC6513544", "30030966"]}, {"Citation": "Xhemali X., Smith J.R., Kebriaei R., Rice S.A., Stamper K.C., Compton M., Singh N.B., Jahanbakhsh S., Rybak M.J. Evaluation of dalbavancin alone and in combination with \u03b2-lactam antibiotics against resistant phenotypes of staphylococcus aureus. J. Antimicrob. Chemother. 2019;74:82\u201386. doi: 10.1093/jac/dky376.", "ArticleIdList": ["10.1093/jac/dky376", "30260409"]}, {"Citation": "D\u00f6mling A., Achatz S., Beck B. Novel anti-tuberculosis agents from MCR libraries. Bioorg. Med. Chem. Lett. 2007;17:5483\u20135486. doi: 10.1016/j.bmcl.2007.04.066.", "ArticleIdList": ["10.1016/j.bmcl.2007.04.066", "17720495"]}, {"Citation": "Nutt R.F., Joullie M.M. Four-component condensation: A new versatile method for the synthesis of substituted prolyl peptides. J. Am. Chem. Soc. 1982;104:5852\u20135853. doi: 10.1021/ja00385a080.", "ArticleIdList": ["10.1021/ja00385a080"]}, {"Citation": "Akritopoulou-Zanze I. Isocyanide-based multicomponent reactions in drug discovery. Curr. Opin. Chem. Biol. 2008;12:324\u2013331. doi: 10.1016/j.cbpa.2008.02.004.", "ArticleIdList": ["10.1016/j.cbpa.2008.02.004", "18312861"]}, {"Citation": "Fan X., Zhang X., Bories C., Loiseau P.M., Torrence P.F. The ugi reaction in the generation of new nucleosides as potential antiviral and antileishmanial agents. Bioorg. Chem. 2007;35:121\u2013136. doi: 10.1016/j.bioorg.2006.08.004.", "ArticleIdList": ["10.1016/j.bioorg.2006.08.004", "16996561"]}, {"Citation": "Musonda C.C., Taylor D., Lehman J., Gut J., Rosenthal P.J., Chibale K. Application of multicomponent reactions to antimalarial drug discovery. Part 1. Parallel synthesis and antiplasmodial activity of new 4-aminoquinoline ugi adducts. Bioorg. Med. Chem. Lett. 2004;14:3901\u20133905. doi: 10.1016/j.bmcl.2004.05.063.", "ArticleIdList": ["10.1016/j.bmcl.2004.05.063", "15225694"]}, {"Citation": "Short K.M., Ching B.W., Mjalli A.M.M. Exploitation of the ugi 4CC reaction: Preparation of small molecule combinatorial libraries via solid phase. Tetrahedron. 1997;53:6653\u20136679. doi: 10.1016/S0040-4020(97)00223-8.", "ArticleIdList": ["10.1016/S0040-4020(97)00223-8"]}, {"Citation": "Musonda C.C., Gut J., Rosenthal P.J., De Souza C., Chibale R.C. Application of multicomponent reactions to antimalarial drug discovery. Part 2. New antiplasmodial and antitrypanosomal 4-aminoquinoline g-and d-lactams via a \u2018catch and release\u2019 protocol. Bioorg. Med. Chem. 2006;14:5605\u20135615. doi: 10.1016/j.bmc.2006.04.035.", "ArticleIdList": ["10.1016/j.bmc.2006.04.035", "16690319"]}, {"Citation": "Linderman R.J., Binet S., Petrich S.R. Enhanced diastereoselectivity in the asymmetric ugi reaction using a new \u201cconvertible\u201d isonitrile. J. Org. Chem. 1999;64:8058. doi: 10.1021/jo994009z.", "ArticleIdList": ["10.1021/jo994009z"]}, {"Citation": "Cohen E. Chitin biochemistry: Synthesis and inhibition. Annu. Rev. Entomol. 1987;32:71\u201393. doi: 10.1146/annurev.en.32.010187.000443.", "ArticleIdList": ["10.1146/annurev.en.32.010187.000443"]}, {"Citation": "Plant A., Thompson P., Williams D.M. Application of the ugi reaction for the one-pot synthesis of uracil polyoxin C analogues. J. Org. Chem. 2009;74:4870\u20134873. doi: 10.1021/jo900244m.", "ArticleIdList": ["10.1021/jo900244m", "19456169"]}, {"Citation": "Neves Filho R.A.W., Stark S., Westermann B., Wessjohann L.A. The multicomponent approach to N-methyl peptides: Total synthesis of antibacterial (\u2212)-viridic acid and analogues. Beilstein J. Org. Chem. 2012;8:2085\u20132090. doi: 10.3762/bjoc.8.234.", "ArticleIdList": ["10.3762/bjoc.8.234", "PMC3511043", "23209543"]}, {"Citation": "Brase S., Encinas A., Keck J., Nising C.F. Chemistry and biology of mycotoxins and related fungal metabolites. Chem. Rev. 2009;109:3903\u20133990. doi: 10.1021/cr050001f.", "ArticleIdList": ["10.1021/cr050001f", "19534495"]}, {"Citation": "Quazi S. Role of artificial intelligence and machine learning in bioinformatics: Drug discovery and drug repurposing. Preprints. 2021:2021050346. doi: 10.20944/preprints202105.0346.v1.", "ArticleIdList": ["10.20944/preprints202105.0346.v1"]}, {"Citation": "Iarani G.M., Moradi R., Mahammadkhani L. Application of multicomponent reactions in the total synthesis of natural peptides. Org. Chem. 2019:18\u201340. doi: 10.24820/ark.5550190.p010.779.", "ArticleIdList": ["10.24820/ark.5550190.p010.779"]}, {"Citation": "Okandeji B.O., Greenwald D.M., Wroten J., Sello J.K. Synthesis and evaluation of inhibitors of bacterial drug efflux pumps of the major facilitator superfamily. Bioorg. Med. Chem. 2011;19:7679\u20137689. doi: 10.1016/j.bmc.2011.10.011.", "ArticleIdList": ["10.1016/j.bmc.2011.10.011", "22055717"]}, {"Citation": "Okamoto K., Sakagami M., Feng F., Togame H., Takemoto H., Ichikawa S., Matsuda A. Total synthesis of pacidamycin D by Cu (I)-catalyzed oxy enamide formation. Org. Lett. 2011;13:5240\u20135243. doi: 10.1021/ol202124b.", "ArticleIdList": ["10.1021/ol202124b", "21902200"]}, {"Citation": "Winn M., Goss R.J., Kimura K.I., Bugg T.D. Antimicrobial nucleoside antibiotics targeting cell wall assembly: Recent advances in structure\u2013function studies and nucleoside biosynthesis. Nat. Prod. Rep. 2010;27:279\u2013304. doi: 10.1039/B816215H.", "ArticleIdList": ["10.1039/B816215H", "20111805"]}, {"Citation": "Fernandes P.B., Swanson R.N., Hardy D.J., Hanson C.W., Coen L., Rasmussen R.R., Chen R.H. Pacidamycins, a novel series of antibiotics with anti-pseudomonas aeruginosa activity. III. Microbiologic profile. J. Antibiot. 1989;42:521\u2013526. doi: 10.7164/antibiotics.42.521.", "ArticleIdList": ["10.7164/antibiotics.42.521", "2498265"]}, {"Citation": "Yan Y.-M., Rao Y., Ding M.-W. One-pot synthesis of multisubstituted benzimidazoles via sequential ugi and catalytic aza-wittig reaction starting from 2-aminobenzoyl azides. J. Org. Chem. 2016;81:1263\u20131268. doi: 10.1021/acs.joc.5b02575.", "ArticleIdList": ["10.1021/acs.joc.5b02575", "26759921"]}, {"Citation": "Mavrova A.T., Yancheva D., Anastassova N., Anichina K., Zvezdanovic J., Djordjevic A., Markovic D., Smelcerovic A. Synthesis, electronic properties, antioxidant and antibacterial activity of some new benzimidazoles. Bioorg. Med. Chem. 2015;23:6317\u20136326. doi: 10.1016/j.bmc.2015.08.029.", "ArticleIdList": ["10.1016/j.bmc.2015.08.029", "26344590"]}, {"Citation": "Pan T., He X., Chen B., Chen H., Geng G., Luo H., Zhang H., Bai C. Development of benzimidazole derivatives to inhibit HIV-1 replication through protecting APOBEC3G protein. Eur. J. Med. Chem. 2015;95:500\u2013513. doi: 10.1016/j.ejmech.2015.03.050.", "ArticleIdList": ["10.1016/j.ejmech.2015.03.050", "25847768"]}, {"Citation": "Vasantha K., Basavarajaswamy G., Rai M.V., Boja P., Pai V.R., Shruthi N., Bhat M. Rapid \u2018one-pot\u2019synthesis of a novel benzimidazole-5-carboxylate and its hydrazone derivatives as potential anti-inflammatory and antimicrobial agents. Bioorg. Med. Chem. Lett. 2015;25:1420\u20131426. doi: 10.1016/j.bmcl.2015.02.043.", "ArticleIdList": ["10.1016/j.bmcl.2015.02.043", "25765910"]}, {"Citation": "Zeng Y., Li Y., Liu G., Wei Y., Wu Y., Tao L. Antibacterial self-healing hydrogel via the ugi reaction. ACS Appl. Polym. Mater. 2019;2:404\u2013410. doi: 10.1021/acsapm.9b00874.", "ArticleIdList": ["10.1021/acsapm.9b00874"]}, {"Citation": "Reddy T.S., Kulhari H., Reddy V.G., Bansal V., Kamal A., Shukla R. Design, synthesis and biological evaluation of 1, 3-diphenyl-1H-pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents. Eur. J. Med. Chem. 2015;101:790\u2013805. doi: 10.1016/j.ejmech.2015.07.031.", "ArticleIdList": ["10.1016/j.ejmech.2015.07.031", "26231080"]}, {"Citation": "Kesteleyn B.R., Schepens W.B. Assignee. HIV Inhibiting. Volume 3 Tibotec Pharmaceuticals Ltd.; Co Cork, Ireland: 2011. Inventors."}, {"Citation": "Habashita H., Kokubo M., Hamano S.-I., Hamanaka N., Toda M., Shibayama S., Tada H., Sagawa K., Fukushima D., Maeda K., et al. Design, synthesis, and biological evaluation of the combinatorial library with a new spirodiketopiperazine scaffold. discovery of novel potent and selective low-molecular-weight CCR5 antagonists. J. Med. Chem. 2006;49:4140\u20134152. doi: 10.1021/jm060051s.", "ArticleIdList": ["10.1021/jm060051s", "16821774"]}, {"Citation": "Hulme C., Morrissette M.M., Volz F.A., Burns C.J. ChemInform abstract: The solution phase synthesis of diketopiperazine libraries via the ugi reaction: Novel application of armstrong\u2019 s convertible isonitrile. ChemInform. 2010;29 doi: 10.1002/chin.199822110.", "ArticleIdList": ["10.1002/chin.199822110"]}, {"Citation": "Nishizawa R., Nishiyama T., Hisaichi K., Matsunaga N., Minamoto C., Habashita H., Takaoka Y., Toda M., Shibayama S., Tada H., et al. Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite. Bioorganic Med. Chem. Lett. 2007;17:727\u2013731. doi: 10.1016/j.bmcl.2006.10.084.", "ArticleIdList": ["10.1016/j.bmcl.2006.10.084", "17118654"]}, {"Citation": "Maeda K., Nakata H., Koh Y., Miyakawa T., Ogata H., Takaoka Y., Shibayama S., Sagawa K., Fukushima D., Moravek J., et al. Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro. J. Virol. 2004;78:8654\u20138662. doi: 10.1128/JVI.78.16.8654-8662.2004.", "ArticleIdList": ["10.1128/JVI.78.16.8654-8662.2004", "PMC479103", "15280474"]}, {"Citation": "ACS Medical Content and News Staff  2022 Cancer Facts & Figures Cancer|Cancer Death Rate Drops.  [(accessed on 31 March 2022)].  Available online:  https://www.cancer.org/latest-news/facts-and-figures-2022.html."}, {"Citation": "Mullica D.F., Pinney K.G., Mocharla V.P., Dingeman K.M., Bounds A.D., Sappenfield E.L. Characterization and structural analyses of trimethoxy and triethoxybenzo[b]thiophene. J. Chem. Crystallogr. 1998;28:289\u2013295. doi: 10.1023/A:1021853320007.", "ArticleIdList": ["10.1023/A:1021853320007"]}, {"Citation": "Flynn B.L., Hamel E., Jung M.K. ChemInform abstract: One-pot synthesis of benzo[B]furan and indole inhibitors of tubulin polymerization. ChemInform. 2010;33 doi: 10.1002/chin.200238093.", "ArticleIdList": ["10.1002/chin.200238093", "12036378"]}, {"Citation": "Pulley S.R. Chemokine Biology\u2014Basic Research and Clinical Application. Birkh\u00e4user Basel; Basel, Switzerland: 2007. CCR5 antagonists: From discovery to clinical efficacy; pp. 145\u2013163."}, {"Citation": "Crabb C. GlaxoSmithKline ends aplaviroc trials. AIDS. 2006;20:641. doi: 10.1097/01.aids.0000216362.59657.96.", "ArticleIdList": ["10.1097/01.aids.0000216362.59657.96", "16514292"]}, {"Citation": "Szardenings A.K., Burkoth T.S., Lu H.H., Tien D.W., Campbell D.A. A simple procedure for the solid phase synthesis of diketopiperazine and diketomorpholine derivatives. Tetrahedron. 1997;53:6573\u20136593. doi: 10.1016/S0040-4020(97)00218-4.", "ArticleIdList": ["10.1016/S0040-4020(97)00218-4"]}, {"Citation": "Wyatt P.G., Allen M.J., Borthwick A.D., Davies D.E., Exall A.M., Hatley R., Irving W.R., Livermore D.G., Miller N.D., Nerozzi F. 5-diketopiperazines as potent and selective oxytocin antagonists. 1. Identifification, stereochemistry and initial SAR. Bioorg. Med. Chem. Lett. 2005;15:2579\u20132582. doi: 10.1016/j.bmcl.2005.03.045.", "ArticleIdList": ["10.1016/j.bmcl.2005.03.045", "15863320"]}, {"Citation": "Borthwick A.D., Davies D.E., Exall A.M., Livermore D.G., Sollis S.L., Nerozzi F., Allen M.J., Perren M., Shabbir S.S., Woollard P.M. Wyatt PG: 2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 2. Synthesis, chirality and pharmacokinetics. J. Med. Chem. 2005;48:6956\u20136969. doi: 10.1021/jm050557v.", "ArticleIdList": ["10.1021/jm050557v", "16250654"]}, {"Citation": "Liddle J., Allen M.J., Borthwick A.D., Brooks D.P., Davies D.E., Edwards R.M., Exall A.M., Hamlett C., Irving W.R., Mason A.M., et al. The discovery of GSK221149A: A potent and selective oxytocin antagonist. Bioorg. Med. Chem. Lett. 2008;18:90\u201394. doi: 10.1016/j.bmcl.2007.11.008.", "ArticleIdList": ["10.1016/j.bmcl.2007.11.008", "18032036"]}, {"Citation": "Filosa R., Marinozzi M., Constantino G., Hermit M.B., Thomsen C., Pellicciari R. Synthesis and biological evaluation of (2S)-and (2R)-2-(30-phosphonobicyclo [1.1.1] pentyl) glycines as novel group III selective metabotropic glutamate receptor ligands. Bioorg. Med. Chem. 2006;14:3811\u20133817. doi: 10.1016/j.bmc.2006.01.027.", "ArticleIdList": ["10.1016/j.bmc.2006.01.027", "16460952"]}, {"Citation": "K\u00fchnert S., Zemolka S., Haurand M., Schiene K. Substituted imidazo [2, 1-b] thiazole compounds and their use for producing drugs. PCT Int. Appl. 2020;95:103496. doi: 10.1016/j.bioorg.2019.103496.", "ArticleIdList": ["10.1016/j.bioorg.2019.103496"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "1"}, {"Year": "2023", "Month": "4", "Day": "26"}, {"Year": "2023", "Month": "4", "Day": "28"}, {"Year": "2023", "Month": "5", "Day": "27", "Hour": "9", "Minute": "43"}, {"Year": "2023", "Month": "5", "Day": "27", "Hour": "9", "Minute": "42"}, {"Year": "2023", "Month": "5", "Day": "27", "Hour": "1", "Minute": "2"}, {"Year": "2023", "Month": "5", "Day": "4"}], "PublicationStatus": "epublish", "ArticleIdList": ["37237752", "PMC10215305", "10.3390/antibiotics12050849", "antibiotics12050849"]}}], "PubmedBookArticle": []}